白血球増加症の世界市場レポート (2025年)

白血球増加症の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.4％で63億9,000万米ドルに成長します。予測期間中に予測される成長は、がんや自己免疫疾患などの慢性疾患の有病率の増加、早期かつ正確な診断ソリューションに対する需要の高まり、免疫系機能不全に陥りやすい高齢者人口の増加、早期発見につながる意識の高まりと定期的な健康診断、世界のヘルスケア支出の全体的な増加など、いくつかの要因に起因しています。予測期間中に予想される主な動向には、診断ツールへの人工知能の統合、携帯型ポイントオブケア白血球計数装置の開発、遠隔患者モニタリングのための遠隔医療プラットフォームの採用、自動白血球計数技術の発展、個別化治療戦略を可能にするデジタル健康記録の利用などがあります。

血液関連疾患の増加は、今後数年間の白血球増加症市場の成長を促進すると予測されています。これらの疾患は、赤血球や白血球、血小板、血漿などの血液成分に影響を及ぼす病状を伴う。このような疾患の有病率は、特に高齢化により上昇しています。高齢者は、免疫システムの弱体化や健康合併症の蓄積により、貧血、白血病、凝固障害などの状態に陥りやすいからです。これらの疾患は、白血球数の上昇を引き起こすことが多く、白血球増加症の重要な指標となっています。このことは、早期発見の改善、モニタリングソリューションの改善、より効果的な治療方法の必要性を強調しています。例えば、米国を拠点とするがん団体である米国がん協会は、2024年に6万2,770件の白血病の新規症例を報告し、2023年の5万9,610件から顕著な増加を示しました。その結果、血液関連疾患の有病率の増加が白血球増加症市場の成長に拍車をかけています。

白血球増加症市場の主要企業は、病気の早期発見を改善し、診断精度を高め、個別化された治療戦略をサポートするために、診断プラットフォームに人工知能を組み込む動きを強めています。AIを搭載した診断ツールは、機械学習、ディープラーニング、自然言語処理などの技術を活用して医療データを解釈し、病気の診断を支援または自動化します。例えば、2024年12月、オランダに本社を置くヘルスケア企業のKoninklijke Philips NVはCT 5300システムを発表しました。このシステムは独自のAI技術を統合し、コンピュータ断層撮影（CT）画像処理プロセスを最適化します。このシステムにはCTスマートワークフローが含まれており、Precise Position、Precise Cardiac、Precise BrainといったAIを搭載したツールがスキャンのセットアップを効率化し、診断精度を高め、放射線被曝を最小限に抑えます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場のマクロ経済シナリオ：金利・インフレ・地政学・貿易戦争・関税・コロナ禍と回復が市場に及ぼす影響を含む

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の白血球増加症市場：PESTEL分析（政治・社会・技術・環境・法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の白血球増加症市場：成長率分析
• 世界の白血球増加症の市場規模・成長率：実績値、2019～2024年
• 世界の白血球増加症の市場規模・成長率：予測値、2024～2029年、2034年
• 世界の白血球増加症市場：総有効市場（TAM）

第6章 市場セグメンテーション

• 世界の白血球増加症市場：疾患の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 感染症
• 炎症
• 白血病
• ストレス反応
• 世界の白血球増加症市場：診断法の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 血液検査
• 骨髄生検
• 画像技術
• 世界の白血球増加症市場：流通チャネル別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 病院薬局
• オンライン薬局
• 小売薬局
• 世界の白血球増加症市場：エンドユーザー別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 病院
• 診断検査室
• 研究機関
• 世界の白血球増加症市場：感染症の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 細菌感染症
• ウイルス感染
• 寄生虫感染症
• 真菌感染症
• 世界の白血球増加症市場：炎症の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 自己免疫疾患
• アレルギー反応
• 慢性炎症性疾患
• 急性炎症反応
• 世界の白血球増加症市場：白血病の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 急性リンパ性白血病（ALL）
• 慢性リンパ性白血病（CLL）
• 急性骨髄性白血病（AML）
• 慢性骨髄性白血病（CML）
• 世界の白血球増加症市場：ストレス反応の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 身体的外傷
• 手術
• 重度の不安
• 激しい運動

第7章 地域別・国別の分析

• 世界の白血球増加症市場：地域別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 世界の白血球増加症市場：国別、実績値・予測値、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 白血球増加症市場：競合情勢
• 白血球増加症市場：企業プロファイル
  • McKesson Corporation（概要、製品・サービス、戦略、財務分析）
  • Pfizer Inc.（概要、製品・サービス、戦略、財務分析）
  • Johnson & Johnson（概要、製品・サービス、戦略、財務分析）
  • Siemens Healthineers AG（概要、製品・サービス、戦略、財務分析）
  • Roche Diagnostics AG（概要、製品・サービス、戦略、財務分析）

第31章 その他の大手企業と革新的企業

• Bristol Myers Squibb
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Novartis International AG
• Danaher Corporation
• Merck KGaA
• Becton, Dickinson and Company（BD）
• Laboratory Corporation of America Holdings（LabCorp）
• Quest Diagnostics
• Agilent Technologies Inc.
• Grifols SA
• Hologic Inc.
• Illumina Inc.
• PerkinElmer Inc.
• Sysmex Corporation

第32章 世界市場：競合ベンチマーキング・ダッシュボード

第33章 主要な企業合併・買収 (M&A)

第34章 最近の市場動向

第35章 市場の潜在力の高い国・部門と戦略

• 白血球増加症市場：最新機会を提供する国（2029年）
• 白血球増加症市場：最新機会を提供する部門（2029年）
• 白血球増加症市場：成長戦略（2029年）
  • 市場動向に基づく戦略
  • 競争戦略

第36章 付録

Leukocytosis is a condition characterized by an elevated white blood cell (WBC) count in the bloodstream, often indicating an underlying infection, inflammation, or immune response. The primary purpose of treating this condition is to strengthen the body's defense mechanisms by increasing the number of WBCs to combat infections or heal injuries.

The main types of diseases associated with leukocytosis include infections, inflammation, leukemia, and stress response. Infections trigger leukocytosis as the immune system responds to invading pathogens by boosting the production of white blood cells (particularly neutrophils) to combat bacterial threats. Diagnosis of leukocytosis typically involves blood tests, bone marrow biopsies, and imaging techniques. The condition is managed and treated through various distribution channels, such as hospital pharmacies, online pharmacies, and retail pharmacies. Key end users of leukocytosis-related diagnostics and treatments include hospitals, diagnostic laboratories, and research institutions.

The leukocytosis market research report is one of a series of new reports from The Business Research Company that provides leukocytosis market statistics, including leukocytosis industry global market size, regional shares, competitors with an leukocytosis market share, detailed leukocytosis market segments, market trends and opportunities, and any further data you may need to thrive in the leukocytosis industry. The leukocytosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The leukocytosis market size has grown strongly in recent years. It will grow from $4.89 billion in 2024 to $5.17 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth during the historic period can be attributed to several factors, including the increasing incidence of infections and inflammatory diseases, rising awareness and diagnosis of blood disorders, a higher prevalence of leukemia and other cancers, a growing aging population susceptible to immune dysfunction, and an increase in hospital admissions for chronic illnesses.

The leukocytosis market size is expected to see strong growth in the next few years. It will grow to $6.39 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The projected growth during the forecast period can be attributed to several factors, including the increasing prevalence of chronic illnesses such as cancer and autoimmune diseases, the rising demand for early and precise diagnostic solutions, a growing elderly population prone to immune system dysfunction, heightened awareness and routine health check-ups leading to early detection, and the overall increase in global healthcare spending. Key trends expected during the forecast period include the integration of artificial intelligence into diagnostic tools, the development of portable point-of-care leukocyte count devices, the adoption of telemedicine platforms for remote patient monitoring, advancements in automated leukocyte counting technologies, and the use of digital health records to enable personalized treatment strategies.

The increasing occurrence of blood-related disorders is anticipated to drive the growth of the leukocytosis market in the coming years. These disorders involve medical conditions that impact the components of blood, including red and white blood cells, platelets, and plasma. The prevalence of such diseases is rising, particularly due to aging populations, as older individuals are more prone to conditions such as anemia, leukemia, and clotting disorders because of weakened immune systems and accumulated health complications. These disorders frequently result in elevated white blood cell counts-a key indicator of leukocytosis-underscoring the need for improved early detection, better monitoring solutions, and more effective treatment methods. For example, in 2024, the American Cancer Society, a US-based cancer organization, reported 62,770 new cases of leukemia, marking a notable increase from 59,610 cases in 2023. Consequently, the increasing prevalence of blood-related diseases is fueling the growth of the leukocytosis market.

Leading companies in the leukocytosis market are increasingly incorporating artificial intelligence into diagnostic platforms to improve early disease detection, enhance diagnostic precision, and support personalized treatment strategies. AI-powered diagnostic tools utilize technologies such as machine learning, deep learning, and natural language processing to interpret medical data and aid in or automate disease diagnosis. For instance, in December 2024, Koninklijke Philips NV, a healthcare firm based in the Netherlands, introduced the CT 5300 system. This system integrates proprietary AI technologies to optimize computed tomography (CT) imaging processes. It includes the CT smart workflow, which features AI-powered tools such as Precise Position, Precise Cardiac, and Precise Brain to streamline scan setup, increase diagnostic accuracy, and minimize radiation exposure.

In February 2024, AbbVie Inc., a US-based biopharmaceutical company, completed the acquisition of ImmunoGen Inc. for an undisclosed sum. This strategic move bolsters AbbVie's oncology pipeline by incorporating ImmunoGen's specialized capabilities in antibody-drug conjugates (ADCs), enhancing the company's efforts to develop targeted treatments for blood-related cancers and conditions such as leukocytosis. ImmunoGen Inc. is a biotechnology company based in the US that focuses on ADCs for treating blood cancers, including leukemia, which frequently leads to leukocytosis.

Major players in the leukocytosis market are McKesson Corporation, Pfizer Inc., Johnson & Johnson, Siemens Healthineers AG, Roche Diagnostics AG, Bristol Myers Squibb, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis International AG, Danaher Corporation, Merck KGaA, Becton, Dickinson and Company (BD), Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics, Agilent Technologies Inc., Grifols SA, Hologic Inc., Illumina Inc., PerkinElmer Inc., Sysmex Corporation, Beckman Coulter Diagnostics Inc, Bio-Rad Laboratories, Bio-Techne Corporation, NeoGenomics Laboratories, Inc., DiaSorin S.p.A., DiaSorin S.p.A.

North America was the largest region in the leukocytosis market in 2024. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in leukocytosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the leukocytosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The leukocytosis market includes revenues earned by entities through complete blood count (CBC) testing, white blood cell differential analysis, monitoring and management of underlying conditions, development and administration of targeted therapeutics, and support for clinical research and drug trials focused on hematologic abnormalities. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Leukocytosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on leukocytosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for leukocytosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The leukocytosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Type: Infection; Inflammation; Leukemia; Stress Response
• 2) By Diagnosis Type: Blood Tests; Bone Marrow Biopsy; Imaging Techniques
• 3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies
• 4) By End User: Hospitals; Diagnostic Laboratories; Research Institutions
• Subsegments:
• 1) By Infection: Bacterial Infections; Viral Infections; Parasitic Infections; Fungal Infections
• 2) By Leukemia: Acute Lymphocytic Leukemia (ALL); Chronic Lymphocytic Leukemia (CLL); Acute Myeloid Leukemia (AML); Chronic Myeloid Leukemia (CML)
• 3) By Inflammation: Autoimmune Diseases; Allergic Reactions; Chronic Inflammatory Conditions; Acute Inflammatory Responses
• 4) By Stress Response: Physical Trauma; Surgery; Severe Anxiety; Intense Exercise
• Companies Mentioned: McKesson Corporation; Pfizer Inc.; Johnson & Johnson; Siemens Healthineers AG; Roche Diagnostics AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Leukocytosis Market Characteristics

3. Leukocytosis Market Trends And Strategies

4. Leukocytosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Leukocytosis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Leukocytosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Leukocytosis Market Growth Rate Analysis
• 5.4. Global Leukocytosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Leukocytosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Leukocytosis Total Addressable Market (TAM)

6. Leukocytosis Market Segmentation

• 6.1. Global Leukocytosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infection
• Inflammation
• Leukemia
• Stress Response
• 6.2. Global Leukocytosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Tests
• Bone Marrow Biopsy
• Imaging Techniques
• 6.3. Global Leukocytosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies
• 6.4. Global Leukocytosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Laboratories
• Research Institutions
• 6.5. Global Leukocytosis Market, Sub-Segmentation Of Infection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bacterial Infections
• Viral Infections
• Parasitic Infections
• Fungal Infections
• 6.6. Global Leukocytosis Market, Sub-Segmentation Of Inflammation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autoimmune Diseases
• Allergic Reactions
• Chronic Inflammatory Conditions
• Acute Inflammatory Responses
• 6.7. Global Leukocytosis Market, Sub-Segmentation Of Leukemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Lymphocytic Leukemia (ALL)
• Chronic Lymphocytic Leukemia (CLL)
• Acute Myeloid Leukemia (AML)
• Chronic Myeloid Leukemia (CML)
• 6.8. Global Leukocytosis Market, Sub-Segmentation Of Stress Response, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Physical Trauma
• Surgery
• Severe Anxiety
• Intense Exercise

7. Leukocytosis Market Regional And Country Analysis

• 7.1. Global Leukocytosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Leukocytosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Leukocytosis Market

• 8.1. Asia-Pacific Leukocytosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Leukocytosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Leukocytosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Leukocytosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Leukocytosis Market

• 9.1. China Leukocytosis Market Overview
• 9.2. China Leukocytosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Leukocytosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Leukocytosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Leukocytosis Market

• 10.1. India Leukocytosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Leukocytosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Leukocytosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Leukocytosis Market

• 11.1. Japan Leukocytosis Market Overview
• 11.2. Japan Leukocytosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Leukocytosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Leukocytosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Leukocytosis Market

• 12.1. Australia Leukocytosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Leukocytosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Leukocytosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Leukocytosis Market

• 13.1. Indonesia Leukocytosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Leukocytosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Leukocytosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Leukocytosis Market

• 14.1. South Korea Leukocytosis Market Overview
• 14.2. South Korea Leukocytosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Leukocytosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Leukocytosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Leukocytosis Market

• 15.1. Western Europe Leukocytosis Market Overview
• 15.2. Western Europe Leukocytosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Leukocytosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Leukocytosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Leukocytosis Market

• 16.1. UK Leukocytosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Leukocytosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Leukocytosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Leukocytosis Market

• 17.1. Germany Leukocytosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Leukocytosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Leukocytosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Leukocytosis Market

• 18.1. France Leukocytosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Leukocytosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Leukocytosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Leukocytosis Market

• 19.1. Italy Leukocytosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Leukocytosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Leukocytosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Leukocytosis Market

• 20.1. Spain Leukocytosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Leukocytosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Leukocytosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Leukocytosis Market

• 21.1. Eastern Europe Leukocytosis Market Overview
• 21.2. Eastern Europe Leukocytosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Leukocytosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Leukocytosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Leukocytosis Market

• 22.1. Russia Leukocytosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Leukocytosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Leukocytosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Leukocytosis Market

• 23.1. North America Leukocytosis Market Overview
• 23.2. North America Leukocytosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Leukocytosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Leukocytosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Leukocytosis Market

• 24.1. USA Leukocytosis Market Overview
• 24.2. USA Leukocytosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Leukocytosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Leukocytosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Leukocytosis Market

• 25.1. Canada Leukocytosis Market Overview
• 25.2. Canada Leukocytosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Leukocytosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Leukocytosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Leukocytosis Market

• 26.1. South America Leukocytosis Market Overview
• 26.2. South America Leukocytosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Leukocytosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Leukocytosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Leukocytosis Market

• 27.1. Brazil Leukocytosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Leukocytosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Leukocytosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Leukocytosis Market

• 28.1. Middle East Leukocytosis Market Overview
• 28.2. Middle East Leukocytosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Leukocytosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Leukocytosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Leukocytosis Market

• 29.1. Africa Leukocytosis Market Overview
• 29.2. Africa Leukocytosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Leukocytosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Leukocytosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Leukocytosis Market Competitive Landscape And Company Profiles

• 30.1. Leukocytosis Market Competitive Landscape
• 30.2. Leukocytosis Market Company Profiles
  • 30.2.1. McKesson Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Roche Diagnostics AG Overview, Products and Services, Strategy and Financial Analysis

31. Leukocytosis Market Other Major And Innovative Companies

• 31.1. Bristol Myers Squibb
• 31.2. Thermo Fisher Scientific Inc.
• 31.3. Abbott Laboratories
• 31.4. Novartis International AG
• 31.5. Danaher Corporation
• 31.6. Merck KGaA
• 31.7. Becton, Dickinson and Company (BD)
• 31.8. Laboratory Corporation of America Holdings (LabCorp)
• 31.9. Quest Diagnostics
• 31.10. Agilent Technologies Inc.
• 31.11. Grifols SA
• 31.12. Hologic Inc.
• 31.13. Illumina Inc.
• 31.14. PerkinElmer Inc.
• 31.15. Sysmex Corporation

32. Global Leukocytosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Leukocytosis Market

34. Recent Developments In The Leukocytosis Market

35. Leukocytosis Market High Potential Countries, Segments and Strategies

• 35.1 Leukocytosis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Leukocytosis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Leukocytosis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer